Lifecore Accounts Payable vs Retained Earnings Analysis

LFCR Stock   5.84  0.06  1.04%   
Lifecore Biomedical financial indicator trend analysis is infinitely more than just investigating Lifecore Biomedical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Lifecore Biomedical is a good investment. Please check the relationship between Lifecore Biomedical Accounts Payable and its Retained Earnings accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.

Accounts Payable vs Retained Earnings

Accounts Payable vs Retained Earnings Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Lifecore Biomedical Accounts Payable account and Retained Earnings. At this time, the significance of the direction appears to have strong relationship.
The correlation between Lifecore Biomedical's Accounts Payable and Retained Earnings is 0.71. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Retained Earnings in the same time period over historical financial statements of Lifecore Biomedical, assuming nothing else is changed. The correlation between historical values of Lifecore Biomedical's Accounts Payable and Retained Earnings is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Lifecore Biomedical are associated (or correlated) with its Retained Earnings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Retained Earnings has no effect on the direction of Accounts Payable i.e., Lifecore Biomedical's Accounts Payable and Retained Earnings go up and down completely randomly.

Correlation Coefficient

0.71
Relationship DirectionPositive 
Relationship StrengthSignificant

Accounts Payable

An accounting item on the balance sheet that represents Lifecore Biomedical obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Lifecore Biomedical are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.
Most indicators from Lifecore Biomedical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Lifecore Biomedical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.At this time, Lifecore Biomedical's Selling General Administrative is relatively stable compared to the past year. As of 06/01/2024, Tax Provision is likely to grow to about 363.5 K, while Enterprise Value Over EBITDA is likely to drop 7.98.
 2021 2023 2024 (projected)
Total Revenue185.8M213.7M323.1M
Interest Expense17.4M19.9M20.8M

Lifecore Biomedical fundamental ratios Correlations

0.580.680.880.810.830.590.550.91-0.510.98-0.71-0.510.710.70.45-0.290.70.80.80.560.970.26-0.68-0.46-0.67
0.580.570.760.080.871.0-0.320.39-0.80.45-0.54-0.80.550.940.950.090.70.950.860.870.68-0.28-0.41-0.33-0.15
0.680.570.710.410.680.560.130.44-0.380.63-0.33-0.390.710.590.51-0.390.70.670.660.530.660.03-0.65-0.56-0.52
0.880.760.710.530.850.760.250.74-0.610.8-0.65-0.610.620.70.62-0.020.720.880.890.850.890.1-0.52-0.44-0.45
0.810.080.410.530.50.090.880.88-0.160.9-0.46-0.160.490.25-0.02-0.410.310.380.330.150.70.44-0.6-0.29-0.7
0.830.870.680.850.50.880.10.64-0.860.75-0.6-0.860.680.860.8-0.070.760.940.840.810.86-0.23-0.58-0.34-0.39
0.591.00.560.760.090.88-0.310.39-0.830.45-0.54-0.830.550.930.950.10.710.940.860.870.68-0.31-0.4-0.31-0.15
0.55-0.320.130.250.880.1-0.310.710.20.69-0.380.210.1-0.14-0.47-0.25-0.06-0.01-0.02-0.190.380.56-0.25-0.1-0.54
0.910.390.440.740.880.640.390.71-0.270.94-0.71-0.270.490.530.22-0.240.40.650.580.40.830.5-0.55-0.36-0.63
-0.51-0.8-0.38-0.61-0.16-0.86-0.830.2-0.27-0.410.391.0-0.45-0.72-0.81-0.19-0.67-0.74-0.69-0.74-0.620.60.280.030.08
0.980.450.630.80.90.750.450.690.94-0.41-0.7-0.410.630.580.29-0.310.580.70.670.450.910.33-0.65-0.43-0.7
-0.71-0.54-0.33-0.65-0.46-0.6-0.54-0.38-0.710.39-0.70.4-0.15-0.64-0.28-0.24-0.29-0.66-0.57-0.43-0.64-0.10.10.230.23
-0.51-0.8-0.39-0.61-0.16-0.86-0.830.21-0.271.0-0.410.4-0.45-0.72-0.8-0.2-0.66-0.74-0.69-0.74-0.610.610.270.030.07
0.710.550.710.620.490.680.550.10.49-0.450.63-0.15-0.450.650.62-0.70.890.670.750.460.80.12-0.94-0.58-0.68
0.70.940.590.70.250.860.93-0.140.53-0.720.58-0.64-0.720.650.87-0.130.730.950.860.690.77-0.12-0.55-0.41-0.33
0.450.950.510.62-0.020.80.95-0.470.22-0.810.29-0.28-0.80.620.87-0.030.730.860.80.820.59-0.35-0.47-0.3-0.13
-0.290.09-0.39-0.02-0.41-0.070.1-0.25-0.24-0.19-0.31-0.24-0.2-0.7-0.13-0.03-0.39-0.07-0.130.23-0.3-0.440.810.520.72
0.70.70.70.720.310.760.71-0.060.4-0.670.58-0.29-0.660.890.730.73-0.390.750.910.60.83-0.12-0.7-0.48-0.46
0.80.950.670.880.380.940.94-0.010.65-0.740.7-0.66-0.740.670.950.86-0.070.750.910.840.85-0.06-0.58-0.44-0.38
0.80.860.660.890.330.840.86-0.020.58-0.690.67-0.57-0.690.750.860.8-0.130.910.910.780.9-0.02-0.57-0.44-0.4
0.560.870.530.850.150.810.87-0.190.4-0.740.45-0.43-0.740.460.690.820.230.60.840.780.64-0.23-0.33-0.31-0.12
0.970.680.660.890.70.860.680.380.83-0.620.91-0.64-0.610.80.770.59-0.30.830.850.90.640.16-0.72-0.46-0.64
0.26-0.280.030.10.44-0.23-0.310.560.50.60.33-0.10.610.12-0.12-0.35-0.44-0.12-0.06-0.02-0.230.16-0.28-0.33-0.44
-0.68-0.41-0.65-0.52-0.6-0.58-0.4-0.25-0.550.28-0.650.10.27-0.94-0.55-0.470.81-0.7-0.58-0.57-0.33-0.72-0.280.60.83
-0.46-0.33-0.56-0.44-0.29-0.34-0.31-0.1-0.360.03-0.430.230.03-0.58-0.41-0.30.52-0.48-0.44-0.44-0.31-0.46-0.330.60.51
-0.67-0.15-0.52-0.45-0.7-0.39-0.15-0.54-0.630.08-0.70.230.07-0.68-0.33-0.130.72-0.46-0.38-0.4-0.12-0.64-0.440.830.51
Click cells to compare fundamentals

Lifecore Biomedical Account Relationship Matchups

Lifecore Biomedical fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets541.3M502.9M295.2M295.4M339.8M246.8M
Short Long Term Debt Total221.1M221.4M153.2M153.1M176.1M184.9M
Other Current Liab19.0M20.3M16.9M17.1M19.6M12.6M
Total Current Liabilities164.4M101.9M79.2M79.4M91.3M55.4M
Total Stockholder Equity231.0M202.8M107.9M108.1M124.4M139.4M
Property Plant And Equipment Net200.0M217.7M200.4M139.0M159.9M167.9M
Net Debt220.8M220.1M151.5M151.4M174.2M182.9M
Retained Earnings71.2M38.6M(58.9M)(58.7M)(67.5M)(64.1M)
Accounts Payable54.0M51.6M47.6M15.8M18.2M23.5M
Cash1.1M360K1.3M1.6M1.5M1.4M
Non Current Assets Total386.1M384.2M354.6M171.4M197.2M160.7M
Non Currrent Assets Other(9.7M)(25.3M)(26.7M)3.0M2.7M2.8M
Cash And Short Term Investments1.1M360K1.3M1.6M1.5M1.4M
Common Stock Shares Outstanding29.2M29.3M29.5M29.5M33.9M25.9M
Liabilities And Stockholders Equity541.3M502.9M295.2M295.4M339.8M246.8M
Non Current Liabilities Total145.9M198.3M108.0M107.9M124.1M130.3M
Inventory66.3M69.7M66.8M67.0M77.0M80.9M
Other Current Assets8.3M14.2M7.4M7.1M6.3M9.0M
Other Stockholder Equity160.3M162.6M165.5M167.4M192.5M118.6M
Total Liab310.3M300.1M187.2M187.3M215.4M226.2M
Total Current Assets157.1M148.3M123.7M124.0M142.6M86.1M
Short Term Debt61.8M93.4M32.9M45.6M52.5M55.1M
Net Receivables76.2M70.0M48.2M48.3M55.6M35.4M
Intangible Assets45.2M38.1M36.1M15.6M17.9M17.0M
Current Deferred Revenue499K352K1.1M919K827.1K1.3M
Good Will54.5M76.7M69.4M13.9M16.0M15.2M
Accumulated Other Comprehensive Income64K(2.8M)(1.4M)(586K)(527.4K)(553.8K)
Other Liab14.6M11.3M422K3.5M3.1M3.0M
Net Tangible Assets123.6M143.2M78.5M(19.9M)(17.9M)(17.0M)
Other Assets2.2M157.7M3.0M3.2M3.7M3.5M
Long Term Debt101.4M164.9M97.6M101.3M116.5M121.5M
Capital Lease Obligations30.8M27.5M15.0M11.0M9.9M14.1M
Net Invested Capital421.4M396.7M246.1M99.9M89.9M85.4M
Short Long Term Debt89.0M29M40.6M488K439.2K417.2K
Non Current Liabilities Other4.6M3.6M190K3.1M2.8M2.1M
Net Working Capital(7.3M)46.4M44.5M60.5M69.6M73.0M
Property Plant Equipment217.7M137.4M139.0M134.6M121.1M132.6M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Lifecore Biomedical is a strong investment it is important to analyze Lifecore Biomedical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Lifecore Biomedical's future performance. For an informed investment choice regarding Lifecore Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Lifecore Biomedical. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.
To learn how to invest in Lifecore Stock, please use our How to Invest in Lifecore Biomedical guide.
Note that the Lifecore Biomedical information on this page should be used as a complementary analysis to other Lifecore Biomedical's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Complementary Tools for Lifecore Stock analysis

When running Lifecore Biomedical's price analysis, check to measure Lifecore Biomedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lifecore Biomedical is operating at the current time. Most of Lifecore Biomedical's value examination focuses on studying past and present price action to predict the probability of Lifecore Biomedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lifecore Biomedical's price. Additionally, you may evaluate how the addition of Lifecore Biomedical to your portfolios can decrease your overall portfolio volatility.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Global Correlations
Find global opportunities by holding instruments from different markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Is Lifecore Biomedical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lifecore Biomedical. If investors know Lifecore will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lifecore Biomedical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.14)
Revenue Per Share
3.447
Quarterly Revenue Growth
0.208
Return On Assets
(0.05)
Return On Equity
(1.05)
The market value of Lifecore Biomedical is measured differently than its book value, which is the value of Lifecore that is recorded on the company's balance sheet. Investors also form their own opinion of Lifecore Biomedical's value that differs from its market value or its book value, called intrinsic value, which is Lifecore Biomedical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lifecore Biomedical's market value can be influenced by many factors that don't directly affect Lifecore Biomedical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lifecore Biomedical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lifecore Biomedical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lifecore Biomedical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.